Atossa Therapeutics, Inc. · NASDAQ:ATOS

Remmel H. Lawrence received 10,000 Atossa Therapeutics, Inc. shares as an award (Form 4)

Traded May 12, 2026 · Filed May 14, 2026

On May 12, 2026, Remmel H. Lawrence (Director) received 10,000 Atossa Therapeutics, Inc. shares as an award, leaving 10,683 shares. Filed May 14, 2026 (Form 4).

Awarded
10,000 shares
Holding after
10,683 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 12, 2026Common StockAward10,00010,683Direct

Source

View original at SEC

Related